Prevalence of HPV 16 and 18 and attitudes toward HPV vaccination trials in patients with cervical cancer in Mali

• Ibrahima Téguété,

  Affiliation Hôpital Gabriel Touré, Bamako, Mali

  ⨯
• Amadou Dolo,

  Affiliation Hôpital Gabriel Touré, Bamako, Mali

  ⨯
• Kotou Sangare,

  Affiliation Laboratory of Applied Molecular Biology (LBMA), Science and Technologies Faculty (FST), University of Science Techniques and Technologies of Bamako (USTTB), Bamako, Mali

  ⨯
• Abdoulaye Sissoko,

  Affiliation Laboratory of Applied Molecular Biology (LBMA), Science and Technologies Faculty (FST), University of Science Techniques and Technologies of Bamako (USTTB), Bamako, Mali

  ⨯
• Mali Rochas,

  Affiliation GAIA Vaccine Foundation, Providence, RI, United States of America

  ⨯
• Sarah Beseme,

  Affiliation GAIA Vaccine Foundation, Providence, RI, United States of America

  ⨯
• Karamoko Tounkara,

  Affiliation Foundation GAIA, Bamako, Mali

  ⨯
• Shahla Yekta,

  Affiliation GAIA Vaccine Foundation, Providence, RI, United States of America

  ⨯
• Anne S. De Groot ,

  * E-mail: dr.annie.degroot@gmail.com

  ¶‡ These authors are joint senior authors on this work.

  Affiliations GAIA Vaccine Foundation, Providence, RI, United States of America, Institute for Immunology and Informatics (iCubed), University of Rhode Island, Providence, RI, United States of America

  ⨯
• Ousmane A. Koita

  ¶‡ These authors are joint senior authors on this work.

  Affiliation Laboratory of Applied Molecular Biology (LBMA), Science and Technologies Faculty (FST), University of Science Techniques and Technologies of Bamako (USTTB), Bamako, Mali

  ⨯